MS

Muhammed Sulfikar Naranath Sulaiman

Active Director Director DIN 10235126
DIN 10235126 First appointment Jul 2023
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Muhammed Sulfikar Naranath Sulaiman

Data last updated:

Muhammed Sulfikar Naranath Sulaiman is a Director at Vizionin Ikshana Eyecare Foundation (since 2023).

DIN 10235126
Primary Designation Director
First Appointment 11 Jul 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vizionin Ikshana Eyecare Foundation U88900KL2023NPL082354
Director11 Jul 20232023Active

Board colleagues of Muhammed Sulfikar Naranath Sulaiman

Directorship timeline

Open interactive timeline →
Vizionin Ikshana Eyecare Foundation
Premium access

Shareholding and investment profile for Muhammed Sulfikar Naranath Sulaiman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Muhammed Sulfikar Naranath Sulaiman

Muhammed Sulfikar Naranath Sulaiman currently holds 1 directorship: Vizionin Ikshana Eyecare Foundation (Director, since 11 Jul 2023).

Muhammed Sulfikar Naranath Sulaiman was first appointed on 11 Jul 2023 as Director at Vizionin Ikshana Eyecare Foundation.

The current boards of Muhammed Sulfikar Naranath Sulaiman's companies include Haifa Jahan Raihan (Vizionin Ikshana Eyecare Foundation), Raihan Valiyapeedikayil Shamsudheen (Vizionin Ikshana Eyecare Foundation).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available